First Horizon Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.1K | Sell |
1,824
-927
| -34% | -$10.7K | ﹤0.01% | 1398 |
|
|
2025
Q1 | $24K | Sell |
2,751
-315
| -10% | -$2.75K | ﹤0.01% | 1253 |
|
|
2024
Q4 | $44K | Buy |
3,066
+156
| +5% | +$2.24K | ﹤0.01% | 1001 |
|
|
2024
Q3 | $65.7K | Buy |
2,910
+1,012
| +53% | +$22.9K | ﹤0.01% | 868 |
|
|
2024
Q2 | $36.9K | Buy |
1,898
+808
| +74% | +$15.7K | ﹤0.01% | 1056 |
|
|
2024
Q1 | $40.9K | Buy |
1,090
+244
| +29% | +$9.16K | ﹤0.01% | 1053 |
|
|
2023
Q4 | $47.3K | Buy |
846
+60
| +8% | +$3.36K | ﹤0.01% | 961 |
|
|
2023
Q3 | $32.4K | Sell |
786
-277
| -26% | -$11.4K | ﹤0.01% | 1058 |
|
|
2023
Q2 | $59.4K | Sell |
1,063
-421
| -28% | -$23.5K | ﹤0.01% | 817 |
|
|
2023
Q1 | $82.8K | Sell |
1,484
-141
| -9% | -$7.87K | ﹤0.01% | 703 |
|
|
2022
Q4 | $59.2K | Buy |
1,625
+405
| +33% | +$14.8K | ﹤0.01% | 794 |
|
|
2022
Q3 | $34K | Buy |
1,220
+476
| +64% | +$13.3K | ﹤0.01% | 1005 |
|
|
2022
Q2 | $33K | Buy |
744
+739
| +14,780% | +$32.8K | ﹤0.01% | 1096 |
|
|
2022
Q1 | $0 | Sell |
5
-311
| -98% | – | ﹤0.01% | 2275 |
|
|
2021
Q4 | $46K | Buy |
316
+19
| +6% | +$2.77K | ﹤0.01% | 953 |
|
|
2021
Q3 | $43K | Buy |
297
+63
| +27% | +$9.12K | ﹤0.01% | 973 |
|
|
2021
Q2 | $45K | Buy |
234
+117
| +100% | +$22.5K | ﹤0.01% | 827 |
|
|
2021
Q1 | $20K | Buy |
+117
| New | +$20K | ﹤0.01% | 1082 |
|